Medicago Overview
- Year Founded
-
1997
- Status
-
Out of Business
- Employees
-
600
- Latest Deal Type
-
Liquidation
Medicago General Information
Description
Developer of vaccines for infectious diseases based in Quebec City, Quebec. The company uses novel plant-based manufacturing and virus-like particle (VLP) technologies to rapidly develop innovative vaccines and protein-based therapeutics for infectious diseases and emerging public health challenges.
Contact Information
Website
www.medicago.comCorporate Office
- 1020 Route de l'Église
- Suite 600
- Quebec City, Quebec G1V 3V9
- Canada
Corporate Office
- 1020 Route de l'Église
- Suite 600
- Quebec City, Quebec G1V 3V9
- Canada
Medicago Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Bankruptcy: Liquidation | 02-Feb-2023 | Completed | Bankruptcy: Liquidation | |||
| 7. Merger/Acquisition | 20-Sep-2013 | Completed | Generating Revenue | |||
| 6. PIPE | 27-Sep-2011 | Completed | Generating Revenue | |||
| 5. 2PO | 05-Apr-2011 | Completed | Generating Revenue | |||
| 4. PIPE | 01-Nov-2009 | Completed | Generating Revenue | |||
| 3. PIPE | 22-Sep-2008 | Completed | Generating Revenue | |||
| 2. IPO | 30-Aug-2006 | $3.58M | $27.3M | Completed | Generating Revenue | |
| 1. Later Stage VC | 03-Oct-2003 | $24M | $24M | Completed | Generating Revenue |
Medicago Comparisons
Industry
Financing
Details
Medicago Competitors (39)
One of Medicago’s 39 competitors is VLPbio, a Formerly VC-backed company based in Boecillo, Spain.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| VLPbio | Formerly VC-backed | Boecillo, Spain | ||||
| Vir Biotechnology | Formerly VC-backed | San Francisco, CA | ||||
| iBio | Corporation | San Diego, CA | ||||
| Bristol-Myers Squibb | Corporation | Princeton, NJ | ||||
| Cytodyn | Formerly Angel backed | Vancouver, WA |
Medicago Patents
Medicago Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024040325-A1 | Modified influenza b virus hemagglutinin | Inactive | 25-Aug-2022 | ||
| WO-2024026556-A1 | Modified coronavirus s protein | Inactive | 02-May-2022 | ||
| WO-2023049983-A1 | Cpmv vlps displaying sars-cov-2 epitopes | Inactive | 28-Sep-2021 | ||
| WO-2022047575-A1 | Modified coronavims structural protein | Inactive | 01-Sep-2020 | ||
| CA-3191257-A1 | Modified coronavirus structural protein | Pending | 01-Sep-2020 | A61K39/215 |
Medicago Signals
Medicago FAQs
-
When was Medicago founded?
Medicago was founded in 1997.
-
Where is Medicago headquartered?
Medicago is headquartered in Quebec City, Canada.
-
What is the size of Medicago?
Medicago has 600 total employees.
-
What industry is Medicago in?
Medicago’s primary industry is Drug Discovery.
-
Is Medicago a private or public company?
Medicago is a Private company.
-
What is Medicago’s current revenue?
The current revenue for Medicago is .
-
How much funding has Medicago raised over time?
Medicago has raised $96.7M.
-
Who are Medicago’s competitors?
VLPbio, Vir Biotechnology, iBio, Bristol-Myers Squibb, and Cytodyn are some of the 39 competitors of Medicago.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process